Abnormalities, Cardiovascular

1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

RNA Therapeutic
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Ionis Pharmaceuticals
1 program
1
VolanesorsenPhase 1RNA Therapeutic1 trial
Active Trials
NCT02910635Completed52Est. Dec 2016

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Ionis PharmaceuticalsVolanesorsen

Clinical Trials (1)

Total enrollment: 52 patients across 1 trials

A Study to Evaluate the Effect of Volanesorsen on Cardiac Repolarization Conducted in Healthy Volunteers

Start: Sep 2016Est. completion: Dec 201652 patients
Phase 1Completed

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space